U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07695883) titled 'Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study' on July 06.

Brief Summary: MEDHA is a randomized controlled trial among 10-18 year old girls to examine the use-case of the United Nations International Multiple Micronutrient Antenatal Preparation Multiple Micronutrient Supplements (UNIMMAP) multiple micronutrient supplement (MMS) formulation and to test an enhanced regimen (MMS+) with additional nutrients, vs. weekly iron-folic acid as standard of care on outcomes of neurodevelopment, linear growth, biochemical status, bone health, and other functional and health outcomes. This study is an indiv...